SlideShare a Scribd company logo
1 of 5
Download to read offline
RETAIL RESEARCH Jyothy Laboratories Ltd. (JLL) – Q1FY15 Result Update Aug 25, 2014 
HDFC sec Scrip Code Industry CMP (Rs.) Recommended Action Averaging Band (Rs.) Price Target (Rs.) Time Horizon 
JYOLABEQNR FMCG 222.7 Buy at CMP and add on dips 194‐205 240 1 quarter 
In our stock note dated March 28, 2014 we had recommended investors to buy Jyothy Laboratories Ltd. (JLL) at Rs. 201.5 and to average it on dips to Rs. 174‐185 for a 
price target of Rs. 232 over the next quarter. Thereafter, the stock touched a low of Rs. 172 on June 30, 2014 and subsequently met our price target on August 22, 2014. 
Currently, it is quoting at Rs. 222.7. 
JLL’s Q1FY15 results were below our estimates. We present an update on the stock. 
Q1FY15 Results Review (Consolidated) 
Y‐o‐Y 
• The consolidated net sales grew by 15.8% to Rs. 3851.4 mn [Q1FY14: Rs. 3325.8 mn], led by healthy growth across soaps & detergents and home care (up 18.2% & 
14.8% respectively). The growth was driven by a mix of volume growth and price hikes (+8% each). Growth was across the segments like fabric care, dishwashing and 
mosquito repellant segments (up 19%, 24% and 19% Y‐o‐Y) respectively. However, Laundry business reported marginal growth of 4.2% Y‐o‐Y, while Others segment 
(which includes body care, tea & coffee) declined by 23.8% Y‐o‐Y. 
• Operating profit grew at a slower pace by 8.6% Y‐o‐Y, while OPM declined by 89 bps Y‐o‐Y to 13.5% due to increase in raw material cost and higher other expenses (up 
18.9% & 25.4% Y‐o‐Y respectively). The higher raw material cost was on account of inferior mix, arising from lower 12% growth in Ujala fabric whitener. Material Cost / 
Net sales increased by 137 bps Y‐o‐Y to 52.2%. However, further margin contraction was restricted due to relatively lower growth in the employee cost & ASP spends 
(up 9.3% & 5.1% respectively). Segment‐wise, Soaps & Detergents and Home Care both witnessed margin contraction, while Laundry business reported higher losses 
(Rs. 31.7 mn vs loss of Rs. 23.5 mn in Q1FY14). 
• PAT grew by 65.8% Y‐o‐Y, aided by lower interest cost (down 80.4% Y‐o‐Y due to reduction in debt), decline in the effective tax rate (down from 0.4% in Q1FY14 to 
0.1% in Q1FY15) and higher other income (up 170.8% Y‐o‐Y). EPS for the quarter stood at Rs. 2.3 vs Rs. 1.5 in Q1FY14. 
Q‐o‐Q 
• Sequentially, the results appeared impressive possibly due to weak performance in Q4. Net sales grew by 8.2% Q‐o‐Q, led by strong growth in soaps & detergents (up 
29.6% Q‐o‐Q). However, Home Care & Others de‐grew by 37.8% & 6.1% Q‐o‐Q respectively, while Laundry business reported marginal growth of 3.9% Q‐o‐Q. 
• The core operating profit grew by 74.8% Q‐o‐Q, while OPM improved by 513 bps Q‐o‐Q, aided by decline in the ASP cost (down 4.9% Q‐o‐Q). Key segments Soaps & 
Detergents and Home Care both witnessed sequential margin expansion. 
• PAT grew by 97.9% Y‐o‐Y, while PAT margins improved by 500 bps Q‐o‐Q, led by lower interest cost (down 26.4% Q‐o‐Q) and decline in the tax rates (from 0.6% in 
Q4FY14 to 0.1% in Q1FY15). 
RETAIL RESEARCH Page | 1
Quarterly Financials: Consolidated 
(Rs. in Million) 
Particulars Q1FY15 Q1FY14 VAR [%] Q4FY14 VAR [%] 
Net Sales 3851.4 3325.8 15.8 3559.4 8.2 
Other Operating Income 3.4 9.6 -64.2 39.3 -91.3 
Total Income 3854.8 3335.3 15.6 3598.7 7.1 
Total Expenditure 3334.9 2866.0 16.4 3301.3 1.0 
Raw Material Consumed 1233.6 916.2 34.6 1217.4 1.3 
Stock Adjustment -79.3 53.5 - 18.4 -531.5 
Purchase of Finished Goods 857.6 722.1 18.8 786.1 9.1 
Employee Expenses 385.4 361.8 6.5 357.2 7.9 
Advertisement & Sales Promotion 421.1 400.6 5.1 442.6 -4.9 
Other Expenses 516.4 411.8 25.4 479.6 7.7 
Operating Profit 519.9 478.7 8.6 297.4 74.8 
Other Income 19.7 7.3 170.8 26.6 -26.1 
PBIDT 539.6 476.6 13.2 324.1 66.5 
Interest 33.7 172.1 -80.4 45.7 -26.4 
PBDT 505.9 304.5 66.1 278.3 81.8 
Depreciation 81.1 57.1 42.0 62.1 30.6 
PBT 424.8 247.4 71.7 216.2 96.4 
Tax (including DT & FBT) 0.6 1.1 -45.3 1.4 -56.9 
Reported Profit After Tax 424.2 246.3 72.2 214.8 97.4 
Minority Interest/ Share in profit -0.5 -0.6 - 0.3 -252.5 
Reported Profit after minority interest 424.6 246.9 72.0 214.5 97.9 
Extra-ordinary Items 0.0 -9.3 -100.0 0.0 - 
Adjusted PAT 424.6 256.2 65.8 214.5 97.9 
EPS (Rs.) 2.3 1.5 52.0 1.2 97.9 
Equity 181.0 166.0 9.0 181.0 0.0 
FV 1 1 0.0 1 0.0 
OPM (%) 13.5 14.4 -6.2 8.4 61.5 
PATM (%) 11.0 7.7 43.1 6.0 82.9 
(Source: Company, HDFC sec) 
Quarterly Segmental Financials: Consolidated 
(Rs. in Million) 
Particulars Q1FY15 Q1FY14 VAR [%] Q4FY14 VAR [%] 
Segment Revenue 3880.0 3339.6 16.2 3593.4 8.0 
Soaps and Detergent 3045.2 2576.6 18.2 2350.0 29.6 
Home Care 673.0 586.5 14.8 1081.5 ‐37.8 
RETAIL RESEARCH Page | 2
Others 60.2 79.0 ‐23.8 64.0 ‐6.1 
Laundry Services 101.7 97.6 4.2 97.8 3.9 
Less : Inter Segment Revenues 28.6 13.8 107.3 34.0 ‐15.8 
Total Segment Revenue 3851.4 3325.8 15.8 3559.4 8.2 
PBIT 485.9 451.8 7.6 260.7 86.4 
Soaps and Detergent 478.9 460.9 3.9 301.3 59.0 
Home Care 37.1 37.8 ‐1.8 ‐17.3 ‐314.2 
Others 1.5 ‐23.4 ‐ 7.1 ‐78.6 
Laundry Services ‐31.7 ‐23.5 ‐ ‐30.4 ‐ 
Less : Interest 33.7 172.1 ‐80.4 45.7 ‐26.4 
Other Un‐allocable Expenditure 48.7 28.4 71.3 31.0 56.7 
Other Un‐allocable Income/Except Item 21.2 ‐3.8 ‐ 32.3 ‐34.3 
Net Profit/Loss Before Tax 424.8 247.4 71.7 216.2 96.4 
PBITM (%) 12.5 13.5 ‐100 bps 7.3 527 bps 
Soaps and Detergent 15.7 17.9 ‐216 bps 12.8 291 bps 
Home Care 5.5 6.4 ‐93 bps ‐1.6 712 bps 
Others 2.5 ‐29.7 ‐ 11.1 ‐855 bps 
Laundry Services ‐31.2 ‐24.1 ‐ ‐31.1 ‐ 
Capital Employed in Segment 
Soaps and Detergent 2849.1 3069.1 ‐7.2 2768.8 2.9 
Home Care 975.2 957.1 1.9 764.0 27.6 
Others 42.3 75.6 ‐44.1 39.6 6.8 
Laundry Services 1255.6 940.3 33.5 1295.7 ‐3.1 
Total Capital Employed 5122.2 5042.1 1.6 4868.1 5.2 
Add : Unallocable Assets Less Liabilities 2628.3 1640.5 60.2 2491.4 5.5 
Total Capital Employed in the Company 7750.6 6682.5 16.0 7359.6 5.3 
(Source: Company, HDFC sec) 
Other Key Highlights / Developments: 
• Ujala Fabric whitener grew at a slower pace by 12% on a high base of the last year with a volume growth of 6%. The management expects Ujala Fabric whitener to 
achieve better growth rates in the coming quarters. 
• The company has re‐launched Henko Matic in the premium to mild‐premium detergent segment with a new proposition (with LINTelligent technology to protect the 
clothes from ageing). The harsh enzymes, soda and bleach result in shredding of fibres during the wash. These broken fibres are called LINT. LINT on the clothes traps 
dirt and stains leaving them dull, rough and faded. The brand was promoted through a digital campaign, social media and on ground tie‐ups. Henko Matic has been 
RETAIL RESEARCH Page | 3
launched with the aim of grabbing a 20% share in the matic segment and a 10% share in the super premium detergent segment in the coming years. The brand has 
higher margins compared with other brands in the portfolio & with increased sales of the brand the detergent segment's margins will improve over the period of time. 
• In dishwashing segment Pril was re‐launched in August 2014 with a new formulation. The company has also launched 225ml bottles and pouches to attract first time 
users to the brand and the liquid format of the dishwashing detergent. 
• Robust growth in mosquito repellent segment was largely driven by strong sales in the liquid segment which now accounts for 25% of the total mosquito repellent 
sales. In the quarter, the company launched a low smoke coil in the domestic market. Going ahead, it is planning to launch a new mix of liquid vaporizers in Q3FY15. 
The liquid vaporizer sales are expected to grow strongly in the coming quarters. 
• The personal care segment revenues declined by 4%, largely on account of a decline in the sales of the Margo soap brand due to a drop in promotions. The 
management expects Margo's sales to revive in the coming quarters. Margo face wash will be launched in the domestic market in September 2014. 
• Non-South revenue contribution was 58%, flat Y-o-Y. The company expects this contribution to rise going forward. 
• The raw material cost inflation stood at 8%, which was mitigated by around 8% price increase during quarter. Inflation was high in palm fatty acid prices and hence the 
company dropped the promotions for Margo soaps during the quarter. The management said that it does not expect any significant increase in the palm oil prices in 
the coming quarters. 
• The management is confident of sustaining the revenue growth momentum in the coming quarters on the back of innovations, increased distribution reach and 
adequate promotional activities. The OPM is expected to remain at 13.5‐14% in the near future. The gross margins are expected to improve going forward, led by a 
revival in growth of high margin products like Ujala fabric whitener. 
• ASP for the FY15 will be around 12‐13%. 
• The debt at consolidated level is around Rs. 4 bn (compared to Rs. 5.27 bn as on March 31, 2014) and cash is Rs. 1.1 bn as on June 30, 2014. 
• The management expects laundry business to be EBIDTA positive by March 2015. 
• The management started reporting consolidated financials on a quarterly basis from Q1FY15 onwards. 
• Effective April 1, 2014. the Company has revised the useful life of certain fixed assets based on Schedule II to the Companies Act, 2013 for the purposes of providing 
depreciation on fixed assets. Accordingly, the carrying amount of the assets as on April 1, 2014 has been depreciated over the remaining revised useful life of the fixed 
assets. Consequently, the depreciation for Q1FY15 is higher and the PBT is lower to the extent of Rs 17.2 mn. Further, an amount of Rs. 20.5 mn (net of tax of Rs. 10.6 
mn) representing the carrying amount of the assets with revised useful life as Nil, has been charged to the opening reserves as on April 1, 2014 pursuant to the 
Companies Act, 2013. In the consolidated unaudited financial result the depreciation for Q1FY15 is higher and profit before tax is lower to the extent of Rs. 21.2 mn. 
Further, an amount of Rs 24 mn (net of tax of Rs 12.4 mn) representing the carrying amount of the assets with revised useful life as Nil, has been charged to opening 
reserves as on April 1, 2014 pursuant to the Companies Act, 2013. 
Conclusion & Recommendation: 
After a subdued Q4FY14, JLL’s Q1FY15 results (Y‐o‐Y) were again below our estimates. Though 15.8% Y‐o‐Y growth in consolidated net sales was healthy, we expected the 
growth to be faster. Margin contraction led by higher material cost was disappointing. However, lower interest cost & tax rates supported the overall PAT growth. 
While the results were disappointing, we expect the growth to recover in the coming quarters. Sales growth would be driven by brand and geographical extension and 
aggressive marketing initiatives. The company’s power brands are expected to do well, especially the flagship brand, Ujala, which would continue to be a major growth 
catalyst. We expect the operating margins to improve over FY14 on the back of improved product mix & cost rationalization. However, the expansion is likely to be 
limited on the back of higher ASP spends, which are expected to be incurred to support the new launches and continued innovations in power brands. Further, we do not 
RETAIL RESEARCH Page | 4
expect JLL’s subsidiary JFSL to be positive at EBIT level for a few more quarters, which would further limit significant margin expansion. Lower interest cost would boost 
the PAT growth in FY15. 
After a weak Q4FY14 & Q1FY15, we fell JLL could find difficult to meet our FY15 projections. Hence we are downgrading our net sales, operating profit & PAT estimates by 
3.3%, 10.4% & 18% respectively. Accordingly revised EPS for FY15 is estimated at Rs. 9.5 (Rs. 11.6 originally estimated). We have incorporated projections for FY16, 
wherein we expect the net sales, operating profit & PAT to grow by 18%, 21.5% & 20.1% respectively. EPS for FY16 is estimated at Rs. 11.4. 
Despite not so impressive performance from FMCG companies in Q1FY15 (in line with overall sector slowdown), the entire FMCG pack (except ITC) has got re‐rated over 
the last two months on expectations of a turnaround in the economic growth & improvement in spending power over the next one year. If JLL impresses the street with 
robust numbers in the coming quarters, it could also be re‐rated gradually going forward. 
Valuing the stock at 21xFY16E EPS, we arrive at a price target of Rs. 240. We recommend investors to buy the stock at current levels and add it on dips to Rs. 194‐205 (17‐ 
18xFY16E EPS) for our price target over the next quarter. 
Financial Estimations: (Consolidated) 
(Rs. in Million) 
Particulars FY12 FY13 FY14E FY14 (Act) FY15 (OE) FY15 (RE) FY16E 
Net Sales 9126.2 11041.5 13581.1 13183.9 16025.7 15491.1 18279.5 
Operating Profit 840.9 1296.7 1928.5 1572.1 2298.4 2060.3 2504.3 
Adjusted PAT 445.8 196.5 1255.2 837.2 2097.1 1719.5 2065.6 
EPS 2.5 1.1 6.9 4.6 11.6 9.5 11.4 
OPM (%) 9.2 11.7 14.2 11.9 14.3 13.3 13.7 
NPM (%) 4.9 1.8 9.2 6.4 13.1 11.1 11.3 
PE 90.4 205.1 32.1 48.1 19.2 23.4 19.5 
*Act = Actual; OE = Original Estimates; RE = Revised Estimates (Source: Company, HDFC sec Estimates) 
Analyst: Mehernosh K. Panthaki – IT, FMCG & Midcaps; Email ID: mehernosh.panthaki@hdfcsec.com 
RETAIL RESEARCH Tel: (022) 3075 3400 Fax: (022) 2496 5066 Corporate Office 
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 
2496 5066 Website: www.hdfcsec.com Email: hdfcsecretailresearch@hdfcsec.com 
Disclaimer: This document has been prepared by HDFC Securities Limited and is meant for sole use by the recipient and not for circulation. This document is not to be reported or copied or made available to 
others. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. The information contained herein is from sources believed reliable. We do not represent that it is accurate or 
complete and it should not be relied upon as such. We may have from time to time positions or options on, and buy and sell securities referred to herein. We may from time to time solicit from, or perform investment 
banking, or other services for, any company mentioned in this document. This report is intended for non-Institutional Clients 
RETAIL RESEARCH Page | 5

More Related Content

What's hot

China Mobile Annual Report
China Mobile Annual ReportChina Mobile Annual Report
China Mobile Annual Report
RachelChoi
 
Presentation Material for 2Q / Mar. 2019
Presentation Material for 2Q / Mar. 2019Presentation Material for 2Q / Mar. 2019
Presentation Material for 2Q / Mar. 2019
RicohLease
 
Fiscal Year Ended March 2020 (FY2019) Financial Highlights
Fiscal Year Ended March 2020 (FY2019)  Financial Highlights Fiscal Year Ended March 2020 (FY2019)  Financial Highlights
Fiscal Year Ended March 2020 (FY2019) Financial Highlights
RicohLease
 
P&G Earnings Growth Exceeds Expectations
P&G Earnings Growth Exceeds ExpectationsP&G Earnings Growth Exceeds Expectations
P&G Earnings Growth Exceeds Expectations
finance3
 
Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014
IndiaNotes.com
 

What's hot (20)

Valuation of Jubilant food works
Valuation of Jubilant food worksValuation of Jubilant food works
Valuation of Jubilant food works
 
2014 year-end results presentation slides
2014 year-end results presentation slides2014 year-end results presentation slides
2014 year-end results presentation slides
 
Saab Q1 Interim Report 2015 (ENG)
Saab Q1 Interim Report 2015 (ENG)Saab Q1 Interim Report 2015 (ENG)
Saab Q1 Interim Report 2015 (ENG)
 
China Mobile Annual Report
China Mobile Annual ReportChina Mobile Annual Report
China Mobile Annual Report
 
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
 
First Quarter Analyst Briefing as at 6 August 2013
First Quarter Analyst Briefing as at 6 August 2013First Quarter Analyst Briefing as at 6 August 2013
First Quarter Analyst Briefing as at 6 August 2013
 
Presentation Material for 2Q / Mar. 2019
Presentation Material for 2Q / Mar. 2019Presentation Material for 2Q / Mar. 2019
Presentation Material for 2Q / Mar. 2019
 
AkzoNobel Investor Update Q1 2014 results
AkzoNobel Investor Update Q1 2014 resultsAkzoNobel Investor Update Q1 2014 results
AkzoNobel Investor Update Q1 2014 results
 
Fiscal Year Ended March 2020 (FY2019) Financial Highlights
Fiscal Year Ended March 2020 (FY2019)  Financial Highlights Fiscal Year Ended March 2020 (FY2019)  Financial Highlights
Fiscal Year Ended March 2020 (FY2019) Financial Highlights
 
“VALUATION OF ORION PHARMA LIMITED”
“VALUATION OF ORION PHARMA LIMITED”“VALUATION OF ORION PHARMA LIMITED”
“VALUATION OF ORION PHARMA LIMITED”
 
Godrej Consumer's Q4 results were slightly below expectations; Neutral
Godrej Consumer's Q4 results were slightly below expectations; NeutralGodrej Consumer's Q4 results were slightly below expectations; Neutral
Godrej Consumer's Q4 results were slightly below expectations; Neutral
 
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
 
AkzoNobel Q3 2015 results Investor update presentation
AkzoNobel Q3 2015 results Investor update presentationAkzoNobel Q3 2015 results Investor update presentation
AkzoNobel Q3 2015 results Investor update presentation
 
HeidelbergCement: Q3 2014 Presentation
HeidelbergCement: Q3 2014 PresentationHeidelbergCement: Q3 2014 Presentation
HeidelbergCement: Q3 2014 Presentation
 
AkzoNobel Q4 and full-year 2014 results Investor Update Presentation
AkzoNobel Q4 and full-year 2014 results Investor Update PresentationAkzoNobel Q4 and full-year 2014 results Investor Update Presentation
AkzoNobel Q4 and full-year 2014 results Investor Update Presentation
 
AkzoNobel Q3 2013 Investor Presentation
AkzoNobel Q3 2013 Investor PresentationAkzoNobel Q3 2013 Investor Presentation
AkzoNobel Q3 2013 Investor Presentation
 
Q4FY15 Results: TCS' performance below expectations
Q4FY15 Results: TCS' performance below expectationsQ4FY15 Results: TCS' performance below expectations
Q4FY15 Results: TCS' performance below expectations
 
Presentation Material for 1Q / Mar. 2020
Presentation Material for 1Q / Mar. 2020Presentation Material for 1Q / Mar. 2020
Presentation Material for 1Q / Mar. 2020
 
P&G Earnings Growth Exceeds Expectations
P&G Earnings Growth Exceeds ExpectationsP&G Earnings Growth Exceeds Expectations
P&G Earnings Growth Exceeds Expectations
 
Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014
 

Similar to Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec

Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
IndiaNotes.com
 
Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010
Angel Broking
 
Hul ru2 qfy2011-251010
Hul ru2 qfy2011-251010Hul ru2 qfy2011-251010
Hul ru2 qfy2011-251010
Angel Broking
 
Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...
Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...
Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...
RicohLease
 

Similar to Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec (20)

Hindustan Unilever Q2FY15 result in line with estimtaes; buy
Hindustan Unilever Q2FY15 result in line with estimtaes; buyHindustan Unilever Q2FY15 result in line with estimtaes; buy
Hindustan Unilever Q2FY15 result in line with estimtaes; buy
 
MindTree: Rupee appreciation drags revenue growth during Q1FY15
MindTree: Rupee appreciation drags revenue growth during Q1FY15MindTree: Rupee appreciation drags revenue growth during Q1FY15
MindTree: Rupee appreciation drags revenue growth during Q1FY15
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutral
 
Dabur India Q1FY15: Maintain neutral
 Dabur India Q1FY15: Maintain neutral Dabur India Q1FY15: Maintain neutral
Dabur India Q1FY15: Maintain neutral
 
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 LIC Housing Finance Q1FY15: Buy for a target of Rs332 LIC Housing Finance Q1FY15: Buy for a target of Rs332
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 
CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
 CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
 
ITC Q1FY15 results in line with estimates; buy - HDFC Sec
ITC Q1FY15 results in line with estimates; buy - HDFC SecITC Q1FY15 results in line with estimates; buy - HDFC Sec
ITC Q1FY15 results in line with estimates; buy - HDFC Sec
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal Oswal
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 Presentation
 
Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010
 
Bajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdBajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; hold
 
Hul ru2 qfy2011-251010
Hul ru2 qfy2011-251010Hul ru2 qfy2011-251010
Hul ru2 qfy2011-251010
 
Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...
Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...
Second Quarter of Fiscal Year Ending March 2018 (FY2017)Briefing on Financial...
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 
Presentation Material for 3Q / Mar. 2020
Presentation Material for 3Q / Mar. 2020Presentation Material for 3Q / Mar. 2020
Presentation Material for 3Q / Mar. 2020
 
FLFLInvestor_PPT_Q3FY19.pdf
FLFLInvestor_PPT_Q3FY19.pdfFLFLInvestor_PPT_Q3FY19.pdf
FLFLInvestor_PPT_Q3FY19.pdf
 
1 q15
1 q151 q15
1 q15
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
IndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec

  • 1. RETAIL RESEARCH Jyothy Laboratories Ltd. (JLL) – Q1FY15 Result Update Aug 25, 2014 HDFC sec Scrip Code Industry CMP (Rs.) Recommended Action Averaging Band (Rs.) Price Target (Rs.) Time Horizon JYOLABEQNR FMCG 222.7 Buy at CMP and add on dips 194‐205 240 1 quarter In our stock note dated March 28, 2014 we had recommended investors to buy Jyothy Laboratories Ltd. (JLL) at Rs. 201.5 and to average it on dips to Rs. 174‐185 for a price target of Rs. 232 over the next quarter. Thereafter, the stock touched a low of Rs. 172 on June 30, 2014 and subsequently met our price target on August 22, 2014. Currently, it is quoting at Rs. 222.7. JLL’s Q1FY15 results were below our estimates. We present an update on the stock. Q1FY15 Results Review (Consolidated) Y‐o‐Y • The consolidated net sales grew by 15.8% to Rs. 3851.4 mn [Q1FY14: Rs. 3325.8 mn], led by healthy growth across soaps & detergents and home care (up 18.2% & 14.8% respectively). The growth was driven by a mix of volume growth and price hikes (+8% each). Growth was across the segments like fabric care, dishwashing and mosquito repellant segments (up 19%, 24% and 19% Y‐o‐Y) respectively. However, Laundry business reported marginal growth of 4.2% Y‐o‐Y, while Others segment (which includes body care, tea & coffee) declined by 23.8% Y‐o‐Y. • Operating profit grew at a slower pace by 8.6% Y‐o‐Y, while OPM declined by 89 bps Y‐o‐Y to 13.5% due to increase in raw material cost and higher other expenses (up 18.9% & 25.4% Y‐o‐Y respectively). The higher raw material cost was on account of inferior mix, arising from lower 12% growth in Ujala fabric whitener. Material Cost / Net sales increased by 137 bps Y‐o‐Y to 52.2%. However, further margin contraction was restricted due to relatively lower growth in the employee cost & ASP spends (up 9.3% & 5.1% respectively). Segment‐wise, Soaps & Detergents and Home Care both witnessed margin contraction, while Laundry business reported higher losses (Rs. 31.7 mn vs loss of Rs. 23.5 mn in Q1FY14). • PAT grew by 65.8% Y‐o‐Y, aided by lower interest cost (down 80.4% Y‐o‐Y due to reduction in debt), decline in the effective tax rate (down from 0.4% in Q1FY14 to 0.1% in Q1FY15) and higher other income (up 170.8% Y‐o‐Y). EPS for the quarter stood at Rs. 2.3 vs Rs. 1.5 in Q1FY14. Q‐o‐Q • Sequentially, the results appeared impressive possibly due to weak performance in Q4. Net sales grew by 8.2% Q‐o‐Q, led by strong growth in soaps & detergents (up 29.6% Q‐o‐Q). However, Home Care & Others de‐grew by 37.8% & 6.1% Q‐o‐Q respectively, while Laundry business reported marginal growth of 3.9% Q‐o‐Q. • The core operating profit grew by 74.8% Q‐o‐Q, while OPM improved by 513 bps Q‐o‐Q, aided by decline in the ASP cost (down 4.9% Q‐o‐Q). Key segments Soaps & Detergents and Home Care both witnessed sequential margin expansion. • PAT grew by 97.9% Y‐o‐Y, while PAT margins improved by 500 bps Q‐o‐Q, led by lower interest cost (down 26.4% Q‐o‐Q) and decline in the tax rates (from 0.6% in Q4FY14 to 0.1% in Q1FY15). RETAIL RESEARCH Page | 1
  • 2. Quarterly Financials: Consolidated (Rs. in Million) Particulars Q1FY15 Q1FY14 VAR [%] Q4FY14 VAR [%] Net Sales 3851.4 3325.8 15.8 3559.4 8.2 Other Operating Income 3.4 9.6 -64.2 39.3 -91.3 Total Income 3854.8 3335.3 15.6 3598.7 7.1 Total Expenditure 3334.9 2866.0 16.4 3301.3 1.0 Raw Material Consumed 1233.6 916.2 34.6 1217.4 1.3 Stock Adjustment -79.3 53.5 - 18.4 -531.5 Purchase of Finished Goods 857.6 722.1 18.8 786.1 9.1 Employee Expenses 385.4 361.8 6.5 357.2 7.9 Advertisement & Sales Promotion 421.1 400.6 5.1 442.6 -4.9 Other Expenses 516.4 411.8 25.4 479.6 7.7 Operating Profit 519.9 478.7 8.6 297.4 74.8 Other Income 19.7 7.3 170.8 26.6 -26.1 PBIDT 539.6 476.6 13.2 324.1 66.5 Interest 33.7 172.1 -80.4 45.7 -26.4 PBDT 505.9 304.5 66.1 278.3 81.8 Depreciation 81.1 57.1 42.0 62.1 30.6 PBT 424.8 247.4 71.7 216.2 96.4 Tax (including DT & FBT) 0.6 1.1 -45.3 1.4 -56.9 Reported Profit After Tax 424.2 246.3 72.2 214.8 97.4 Minority Interest/ Share in profit -0.5 -0.6 - 0.3 -252.5 Reported Profit after minority interest 424.6 246.9 72.0 214.5 97.9 Extra-ordinary Items 0.0 -9.3 -100.0 0.0 - Adjusted PAT 424.6 256.2 65.8 214.5 97.9 EPS (Rs.) 2.3 1.5 52.0 1.2 97.9 Equity 181.0 166.0 9.0 181.0 0.0 FV 1 1 0.0 1 0.0 OPM (%) 13.5 14.4 -6.2 8.4 61.5 PATM (%) 11.0 7.7 43.1 6.0 82.9 (Source: Company, HDFC sec) Quarterly Segmental Financials: Consolidated (Rs. in Million) Particulars Q1FY15 Q1FY14 VAR [%] Q4FY14 VAR [%] Segment Revenue 3880.0 3339.6 16.2 3593.4 8.0 Soaps and Detergent 3045.2 2576.6 18.2 2350.0 29.6 Home Care 673.0 586.5 14.8 1081.5 ‐37.8 RETAIL RESEARCH Page | 2
  • 3. Others 60.2 79.0 ‐23.8 64.0 ‐6.1 Laundry Services 101.7 97.6 4.2 97.8 3.9 Less : Inter Segment Revenues 28.6 13.8 107.3 34.0 ‐15.8 Total Segment Revenue 3851.4 3325.8 15.8 3559.4 8.2 PBIT 485.9 451.8 7.6 260.7 86.4 Soaps and Detergent 478.9 460.9 3.9 301.3 59.0 Home Care 37.1 37.8 ‐1.8 ‐17.3 ‐314.2 Others 1.5 ‐23.4 ‐ 7.1 ‐78.6 Laundry Services ‐31.7 ‐23.5 ‐ ‐30.4 ‐ Less : Interest 33.7 172.1 ‐80.4 45.7 ‐26.4 Other Un‐allocable Expenditure 48.7 28.4 71.3 31.0 56.7 Other Un‐allocable Income/Except Item 21.2 ‐3.8 ‐ 32.3 ‐34.3 Net Profit/Loss Before Tax 424.8 247.4 71.7 216.2 96.4 PBITM (%) 12.5 13.5 ‐100 bps 7.3 527 bps Soaps and Detergent 15.7 17.9 ‐216 bps 12.8 291 bps Home Care 5.5 6.4 ‐93 bps ‐1.6 712 bps Others 2.5 ‐29.7 ‐ 11.1 ‐855 bps Laundry Services ‐31.2 ‐24.1 ‐ ‐31.1 ‐ Capital Employed in Segment Soaps and Detergent 2849.1 3069.1 ‐7.2 2768.8 2.9 Home Care 975.2 957.1 1.9 764.0 27.6 Others 42.3 75.6 ‐44.1 39.6 6.8 Laundry Services 1255.6 940.3 33.5 1295.7 ‐3.1 Total Capital Employed 5122.2 5042.1 1.6 4868.1 5.2 Add : Unallocable Assets Less Liabilities 2628.3 1640.5 60.2 2491.4 5.5 Total Capital Employed in the Company 7750.6 6682.5 16.0 7359.6 5.3 (Source: Company, HDFC sec) Other Key Highlights / Developments: • Ujala Fabric whitener grew at a slower pace by 12% on a high base of the last year with a volume growth of 6%. The management expects Ujala Fabric whitener to achieve better growth rates in the coming quarters. • The company has re‐launched Henko Matic in the premium to mild‐premium detergent segment with a new proposition (with LINTelligent technology to protect the clothes from ageing). The harsh enzymes, soda and bleach result in shredding of fibres during the wash. These broken fibres are called LINT. LINT on the clothes traps dirt and stains leaving them dull, rough and faded. The brand was promoted through a digital campaign, social media and on ground tie‐ups. Henko Matic has been RETAIL RESEARCH Page | 3
  • 4. launched with the aim of grabbing a 20% share in the matic segment and a 10% share in the super premium detergent segment in the coming years. The brand has higher margins compared with other brands in the portfolio & with increased sales of the brand the detergent segment's margins will improve over the period of time. • In dishwashing segment Pril was re‐launched in August 2014 with a new formulation. The company has also launched 225ml bottles and pouches to attract first time users to the brand and the liquid format of the dishwashing detergent. • Robust growth in mosquito repellent segment was largely driven by strong sales in the liquid segment which now accounts for 25% of the total mosquito repellent sales. In the quarter, the company launched a low smoke coil in the domestic market. Going ahead, it is planning to launch a new mix of liquid vaporizers in Q3FY15. The liquid vaporizer sales are expected to grow strongly in the coming quarters. • The personal care segment revenues declined by 4%, largely on account of a decline in the sales of the Margo soap brand due to a drop in promotions. The management expects Margo's sales to revive in the coming quarters. Margo face wash will be launched in the domestic market in September 2014. • Non-South revenue contribution was 58%, flat Y-o-Y. The company expects this contribution to rise going forward. • The raw material cost inflation stood at 8%, which was mitigated by around 8% price increase during quarter. Inflation was high in palm fatty acid prices and hence the company dropped the promotions for Margo soaps during the quarter. The management said that it does not expect any significant increase in the palm oil prices in the coming quarters. • The management is confident of sustaining the revenue growth momentum in the coming quarters on the back of innovations, increased distribution reach and adequate promotional activities. The OPM is expected to remain at 13.5‐14% in the near future. The gross margins are expected to improve going forward, led by a revival in growth of high margin products like Ujala fabric whitener. • ASP for the FY15 will be around 12‐13%. • The debt at consolidated level is around Rs. 4 bn (compared to Rs. 5.27 bn as on March 31, 2014) and cash is Rs. 1.1 bn as on June 30, 2014. • The management expects laundry business to be EBIDTA positive by March 2015. • The management started reporting consolidated financials on a quarterly basis from Q1FY15 onwards. • Effective April 1, 2014. the Company has revised the useful life of certain fixed assets based on Schedule II to the Companies Act, 2013 for the purposes of providing depreciation on fixed assets. Accordingly, the carrying amount of the assets as on April 1, 2014 has been depreciated over the remaining revised useful life of the fixed assets. Consequently, the depreciation for Q1FY15 is higher and the PBT is lower to the extent of Rs 17.2 mn. Further, an amount of Rs. 20.5 mn (net of tax of Rs. 10.6 mn) representing the carrying amount of the assets with revised useful life as Nil, has been charged to the opening reserves as on April 1, 2014 pursuant to the Companies Act, 2013. In the consolidated unaudited financial result the depreciation for Q1FY15 is higher and profit before tax is lower to the extent of Rs. 21.2 mn. Further, an amount of Rs 24 mn (net of tax of Rs 12.4 mn) representing the carrying amount of the assets with revised useful life as Nil, has been charged to opening reserves as on April 1, 2014 pursuant to the Companies Act, 2013. Conclusion & Recommendation: After a subdued Q4FY14, JLL’s Q1FY15 results (Y‐o‐Y) were again below our estimates. Though 15.8% Y‐o‐Y growth in consolidated net sales was healthy, we expected the growth to be faster. Margin contraction led by higher material cost was disappointing. However, lower interest cost & tax rates supported the overall PAT growth. While the results were disappointing, we expect the growth to recover in the coming quarters. Sales growth would be driven by brand and geographical extension and aggressive marketing initiatives. The company’s power brands are expected to do well, especially the flagship brand, Ujala, which would continue to be a major growth catalyst. We expect the operating margins to improve over FY14 on the back of improved product mix & cost rationalization. However, the expansion is likely to be limited on the back of higher ASP spends, which are expected to be incurred to support the new launches and continued innovations in power brands. Further, we do not RETAIL RESEARCH Page | 4
  • 5. expect JLL’s subsidiary JFSL to be positive at EBIT level for a few more quarters, which would further limit significant margin expansion. Lower interest cost would boost the PAT growth in FY15. After a weak Q4FY14 & Q1FY15, we fell JLL could find difficult to meet our FY15 projections. Hence we are downgrading our net sales, operating profit & PAT estimates by 3.3%, 10.4% & 18% respectively. Accordingly revised EPS for FY15 is estimated at Rs. 9.5 (Rs. 11.6 originally estimated). We have incorporated projections for FY16, wherein we expect the net sales, operating profit & PAT to grow by 18%, 21.5% & 20.1% respectively. EPS for FY16 is estimated at Rs. 11.4. Despite not so impressive performance from FMCG companies in Q1FY15 (in line with overall sector slowdown), the entire FMCG pack (except ITC) has got re‐rated over the last two months on expectations of a turnaround in the economic growth & improvement in spending power over the next one year. If JLL impresses the street with robust numbers in the coming quarters, it could also be re‐rated gradually going forward. Valuing the stock at 21xFY16E EPS, we arrive at a price target of Rs. 240. We recommend investors to buy the stock at current levels and add it on dips to Rs. 194‐205 (17‐ 18xFY16E EPS) for our price target over the next quarter. Financial Estimations: (Consolidated) (Rs. in Million) Particulars FY12 FY13 FY14E FY14 (Act) FY15 (OE) FY15 (RE) FY16E Net Sales 9126.2 11041.5 13581.1 13183.9 16025.7 15491.1 18279.5 Operating Profit 840.9 1296.7 1928.5 1572.1 2298.4 2060.3 2504.3 Adjusted PAT 445.8 196.5 1255.2 837.2 2097.1 1719.5 2065.6 EPS 2.5 1.1 6.9 4.6 11.6 9.5 11.4 OPM (%) 9.2 11.7 14.2 11.9 14.3 13.3 13.7 NPM (%) 4.9 1.8 9.2 6.4 13.1 11.1 11.3 PE 90.4 205.1 32.1 48.1 19.2 23.4 19.5 *Act = Actual; OE = Original Estimates; RE = Revised Estimates (Source: Company, HDFC sec Estimates) Analyst: Mehernosh K. Panthaki – IT, FMCG & Midcaps; Email ID: mehernosh.panthaki@hdfcsec.com RETAIL RESEARCH Tel: (022) 3075 3400 Fax: (022) 2496 5066 Corporate Office HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Website: www.hdfcsec.com Email: hdfcsecretailresearch@hdfcsec.com Disclaimer: This document has been prepared by HDFC Securities Limited and is meant for sole use by the recipient and not for circulation. This document is not to be reported or copied or made available to others. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. The information contained herein is from sources believed reliable. We do not represent that it is accurate or complete and it should not be relied upon as such. We may have from time to time positions or options on, and buy and sell securities referred to herein. We may from time to time solicit from, or perform investment banking, or other services for, any company mentioned in this document. This report is intended for non-Institutional Clients RETAIL RESEARCH Page | 5